Battery Partners IX’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
Other funds holding CSBR
NMC
TAM
EIM
MAG
OMC
Battery Partners IX's CSBR Position: Q3 2020 in Review
Battery Partners IX held its Champions Oncology (CSBR) position steady in Q3 2020 at 2,421,673 shares worth $22.4M. The position accounts for 100% of the portfolio, ranked #1.
Battery Partners IX first reported a position in CSBR in Q3 2015 and has held it in 21 quarters since. The position peaked at $34.1M in Q3 2018. 46 funds tracked by Wall St. Rank hold CSBR as of Q3 2020.
- Battery Partners IX held 2,421,673 shares of Champions Oncology worth $22.4M as of Q3 2020.
- Battery Partners IX left its Champions Oncology share count unchanged in Q3 2020.
- Champions Oncology made up 100% of Battery Partners IX's portfolio in Q3 2020, its #1 holding.
- Battery Partners IX first reported a position in Champions Oncology in Q3 2015 and has held it in 21 quarters since.
- Battery Partners IX's Champions Oncology position peaked at $34.1M in Q3 2018.
- 46 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2020.
Based on Battery Partners IX's 13F filing for Q3 2020, filed 16 Nov 2020.